Skip to content

Creation of a Digital Twin for Predicting the Progression of Patients With Chronic Thoracic Aortic Dissection

Creation of a Digital Twin for Predicting the Progression of Patients With Chronic Thoracic Aortic Dissection

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07315178
Acronym
ADEPT
Enrollment
400
Registered
2026-01-02
Start date
2025-11-25
Completion date
2031-11-30
Last updated
2026-01-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Type B Aortic Dissection, Type A Aortic Dissection With Residual Type B Dissection

Brief summary

Aortic dissection causes a tear in the inner layers of the aorta, leading to the formation of a true and false lumen. There are two types of dissection: type A, which affects the ascending aorta, and type B, which affects the descending aorta. Type A aortic dissection is almost always a surgical emergency and involves replacing the ascending aorta with a prosthesis. After this type of dissection, a residual dissection remains in the descending aorta, known as residual type B dissection, which becomes chronic. This requires increased monitoring by MRI or CT scan, which are currently not effective enough to predict the development of an aneurysm that could lead to aortic rupture requiring surgical intervention. Other factors such as blood flow, the forces and mechanisms regulating blood circulation, the mechanics and histology of the aorta, and blood markers could provide a more reliable prediction of the development of an aneurysm. The creation of a digital twin model incorporating all these factors should enable better patient management.

Interventions

OTHERMRI with 4D flow imaging

At 3 months

BIOLOGICALblood sampling

2 tubes of 10 ml blood at inclusion, at 3 months, at 12 months, at 24 months and at 36 months

Sponsors

Centre Hospitalier Universitaire Dijon
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Person who has given written consent * Age \> 18 years * Patient with type A aortic dissection with surgical indication for replacement * Patient with chronic type B aortic dissection, monitored and managed medically, not operated on

Exclusion criteria

* Persons not affiliated with or not covered by a social security scheme * Persons subject to legal protection measures (guardianship) * Persons subject to judicial protection measures * Pregnant women, women in labour or breastfeeding * Adults who are incapacitated or unable to give their consent * Contraindications to MRI: claustrophobia, non-MRI-compatible metal implants, suspected metal foreign body * Severe renal failure (clearance \<30ml/min according to Cockroft due to gadolinium injection) * Uncontrolled asthma * Patients with acute type A aortic dissection who died during or in the post-operative period following surgery to repair the dissection * Patients with a known allergy to gadolinium-based contrast agents * Patients treated for type B aortic dissection who underwent surgery

Design outcomes

Primary

MeasureTime frame
Relevance of combining biomarkers3 months, 1 year, 2 years, 3 years

Countries

France

Contacts

Primary ContactAlain Lalande
alain.lalande@u-bourgogne.fr

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026